Members |
targetComponentId |
Execution |
Non-judicial execution |
Exenteration of orbit with temporalis muscle transplant |
Grafting of temporalis muscle to orbit with exenteration of orbit |
Exenteration of orbit without skin graft, with temporalis muscle transplant |
Grafting of temporalis muscle to orbit with exenteration of orbit |
Exercise stress echocardiography |
Exercise stress echocardiography (procedure) |
Exercise toler test equivocal |
Exercise tolerance test equivocal (finding) |
Exhaust repair agent |
Automotive exhaust repair agent |
Exocrine pancreas TNM finding |
American Joint Committee on Cancer allowable value |
Exogenous substance receptor |
Receptor |
Exon |
Finding related to molecular sequence data |
Exophthalmos producing substance |
Thyroid ophthalmic antibody |
Exoribonuclease |
Exoribonuclease |
Expansive mood |
Elation |
Expected difficult intubation |
Expected difficult tracheal intubation (finding) |
Experimental implant |
Experimental implant |
Exploration of heart |
Exploration procedure |
Exploration of organ NOC |
Exploration procedure |
Exploration of organ NOC NOS |
Exploration procedure |
Exploration of organ NOC OS |
Exploration procedure |
Exploration of sinus track from organ NOC |
Incision and exploration of sinus tract |
Exploration of vein with inspection only |
Exploration of vein |
Exploratory diagn. proced. NOS |
Exploration procedure |
Exploratory diagn. proced. NOS |
Exploration procedure |
Exploratory diagn. procedures |
Exploration procedure |
Exploratory diagnostic procedures |
Exploration procedure |
Explosive nitroglycerin, device |
Explosive glyceryl trinitrate (substance) |
Extensive metabolizer due to cytochrome p450 CYP2D6 variant |
Cytochrome P450 family 2 subfamily D member 6 normal metabolizer (finding) |
Extensor hallucis longus flap |
Flap (substance) |
Exteriorisation of bowel NOS |
Exteriorization of intestine (procedure) |
Exteriorization of bowel NOS |
Exteriorization of intestine (procedure) |
Exteriorization of organ NOC |
Exteriorization by anatomic site |
External cardioassist |
Manual external cardiac massage with closed chest |
External fixator using Ilizerov system |
External fixator using Ilizarov system (physical object) |
External manipulation of organ NOC |
External manipulation |
External migration |
Transperitoneal migration |
External radiotherapy NOS |
Radiotherapy |
External radiotherapy NOS |
Radiotherapy |
External resorption of root of tooth |
External resorption of tooth |
External splintage |
Splint |
Extractable nuclear antigen measurement |
Antibody to extractable nuclear antigen measurement |
Extradural hemorrhage following injury with open intracranial wound and unspecified state of consciousness |
Extradural hemorrhage following injury with open intracranial wound |
Extrahepatic bile ducts TNM finding |
American Joint Committee on Cancer allowable value |
Extravascular hemolysis |
Extravascular hemolysis |
Extremity |
Limb structure |
Extrinsic asthma with status asthmaticus |
Acute severe exacerbation of immunoglobin E-mediated allergic asthma |
Extrusion of a tooth |
Extrusive luxation of tooth |
Extrusion of tooth due to trauma |
Extrusive luxation of tooth |
Exudative senile macular retinal degeneration |
Exudative age-related macular degeneration (disorder) |
Eye site descriptor |
Eye structure |
Eye witness to epileptic seizure |
Social and personal history finding |
Eye, ear, nose AND/OR throat anti-infective agent |
Pharmaceutical / biologic product (product) |
Eye, ear, nose AND/OR throat anti-inflammatory agent |
Pharmaceutical / biologic product (product) |
Eye, ear, nose AND/OR throat antibiotic |
Pharmaceutical / biologic product (product) |
Eye, ear, nose AND/OR throat antiviral |
Pharmaceutical / biologic product (product) |
Eye, ear, nose AND/OR throat preparation |
Pharmaceutical / biologic product (product) |
Eye, ear, nose AND/OR throat sulfonamide preparation |
Pharmaceutical / biologic product (product) |
Eyelid flap |
Flap (substance) |
FH: Drug dependency |
Family history of substance dependency |
FH: Mental [retardation] or [handicap] |
Family history of intellectual disability |
FH: Mental retardation |
Family history of intellectual disability |
FH: Scleroderma |
Family history of scleroderma |
Facial-hemiatrophy (disorder) |
Facial hemiatrophy |
Facilitating operation NOC NOS |
Surgical procedure (procedure) |
Facilitating operation NOC OS |
Surgical procedure (procedure) |
Facilitating operations NOC |
Surgical procedure (procedure) |
Factitious disorder with physical symptoms |
Factitious disorder with predominantly physical signs and symptoms (disorder) |
Factitious disorder with psychological symptoms |
Factitious disorder with predominantly psychological signs and symptoms (disorder) |
Factor IX 1000iu powder for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Factor IX 500iu powder for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Factor VIII 1000iu/von Willebrand factor 2200iu powder and solvent for injection solution vial |
Coagulation factor VIII and von Willebrand factor only product |
Factor VIII 1000iu/von Willebrand factor 2200iu powder for conventional release solution for injection vial |
Coagulation factor VIII and von Willebrand factor only product |
Factor VIII 1000iu/von Willebrand factor 2500iu powder for injection solution |
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
Factor VIII 500iu/von Willebrand factor 1100iu powder and solvent for injection solution vial |
Coagulation factor VIII and von Willebrand factor only product |
Factor VIII 500iu/von Willebrand factor 1100iu powder for conventional release solution for injection vial |
Coagulation factor VIII and von Willebrand factor only product |
Factor VIII 500iu/von Willebrand factor 1250iu powder for injection solution |
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial |
Factor VIII by-passing fraction 1000iu powder and solvent for injection solution vial |
Product containing only anti-inhibitor coagulant complex in parenteral dose form (medicinal product form) |
Factor VIII by-passing fraction 500iu powder and solvent for injection solution vial |
Product containing only anti-inhibitor coagulant complex in parenteral dose form (medicinal product form) |
Faecal occult blood: positive |
Occult blood detected in feces |
Faecal occult blood: trace |
Trace occult blood detected in feces |
Faeces examination NOS |
Examination of faeces |
Failed attempted abortion with acute yellow atrophy of liver |
Failed attempted termination of pregnancy complicated by acute necrosis of liver |
Failed attempted abortion with specified complication, NEC |
Failed attempted abortion with complication (disorder) |
Failed forceps delivery |
Forceps delivery failed (situation) |
Failed instrumental delivery |
Failed instrumental delivery |
Failed vacuum extraction delivery |
Failed ventouse delivery (situation) |
Failure of resorption of root of tooth |
Persistent primary tooth (disorder) |
Falcivibrio |
Mobiluncus |
Falcivibrio grandis |
Mobiluncus mulieris |
Falcivibrio species |
Mobiluncus |
Falcivibrio vaginalis |
Mobiluncus curtisii |
Fallopian tube TNM finding |
American Joint Committee on Cancer allowable value |
Familial alobar holoprosencephaly |
Holoprosencephaly sequence |
Familial amyloid neuropathy, Finnish type |
AGel amyloidosis |
Familial lambdoid synostosis |
Simple craniosynostosis |
Familial lobular glomerulopathy |
Fibronectin glomerulopathy |
Familial multiple café-au-lait macules without neurofibromatosis |
Neurofibromatosis type 6 |
Familial multiple fibrofolliculoma |
Multiple fibrofolliculomas |
Familiar environment |
Familiar environment (finding) |
Families muridae AND/OR gliridae |
Family Muridae (organism) |
Family Aceraceae |
Soapberries |
Family Aceraceae poisoning |
Sapindaceae poisoning (disorder) |
Family Acidaminococcaceae |
Family Veillonellaceae (organism) |